Cargando…
Cost-Effectiveness of Cranberries vs Antibiotics to Prevent Urinary Tract Infections in Premenopausal Women: A Randomized Clinical Trial
BACKGROUND: Urinary tract infections (UTIs) are common and result in an enormous economic burden. The increasing prevalence of antibiotic-resistant microorganisms has stimulated interest in non-antibiotic agents to prevent UTIs. OBJECTIVE: To evaluate the cost-effectiveness of cranberry prophylaxis...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976255/ https://www.ncbi.nlm.nih.gov/pubmed/24705418 http://dx.doi.org/10.1371/journal.pone.0091939 |
_version_ | 1782310260678066176 |
---|---|
author | Bosmans, Judith E. Beerepoot, Mariëlle A. J. Prins, Jan M. ter Riet, Gerben Geerlings, Suzanne E. |
author_facet | Bosmans, Judith E. Beerepoot, Mariëlle A. J. Prins, Jan M. ter Riet, Gerben Geerlings, Suzanne E. |
author_sort | Bosmans, Judith E. |
collection | PubMed |
description | BACKGROUND: Urinary tract infections (UTIs) are common and result in an enormous economic burden. The increasing prevalence of antibiotic-resistant microorganisms has stimulated interest in non-antibiotic agents to prevent UTIs. OBJECTIVE: To evaluate the cost-effectiveness of cranberry prophylaxis compared to antibiotic prophylaxis with trimethoprim-sulfamethoxazole (TMP-SMX) over a 12 month period in premenopausal women with recurrent UTIs. MATERIALS AND METHODS: An economic evaluation was performed alongside a randomized trial. Primary outcome was the number of UTIs during 12 months. Secondary outcomes included satisfaction and quality of life. Healthcare utilization was measured using questionnaires. Missing data were imputed using multiple imputation. Bootstrapping was used to evaluate the cost-effectiveness of the treatments. RESULTS: Cranberry prophylaxis was less effective than TMP-SMX prophylaxis, but the differences in clinical outcomes were not statistically significant. Costs after 12 months in the cranberry group were statistically significantly higher than in the TMP-SMX group (mean difference €249, 95% confidence interval 70 to 516). Cost-effectiveness planes and cost-effectiveness acceptability curves showed that cranberry prophylaxis to prevent UTIs is less effective and more expensive than (dominated by) TMP-SMX prophylaxis. CONCLUSION: In premenopausal women with recurrent UTIs, cranberry prophylaxis is not cost-effective compared to TMP-SMX prophylaxis. However, it was not possible to take into account costs attributed to increased antibiotic resistance within the framework of this randomized trial; modeling studies are recommended to investigate these costs. Moreover, although we based the dosage of cranberry extract on available evidence, this may not be the optimal dosage. Results may change when this optimal dosage is identified. TRIAL REGISTRATION: ISRCTN.org ISRCTN50717094 |
format | Online Article Text |
id | pubmed-3976255 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-39762552014-04-08 Cost-Effectiveness of Cranberries vs Antibiotics to Prevent Urinary Tract Infections in Premenopausal Women: A Randomized Clinical Trial Bosmans, Judith E. Beerepoot, Mariëlle A. J. Prins, Jan M. ter Riet, Gerben Geerlings, Suzanne E. PLoS One Research Article BACKGROUND: Urinary tract infections (UTIs) are common and result in an enormous economic burden. The increasing prevalence of antibiotic-resistant microorganisms has stimulated interest in non-antibiotic agents to prevent UTIs. OBJECTIVE: To evaluate the cost-effectiveness of cranberry prophylaxis compared to antibiotic prophylaxis with trimethoprim-sulfamethoxazole (TMP-SMX) over a 12 month period in premenopausal women with recurrent UTIs. MATERIALS AND METHODS: An economic evaluation was performed alongside a randomized trial. Primary outcome was the number of UTIs during 12 months. Secondary outcomes included satisfaction and quality of life. Healthcare utilization was measured using questionnaires. Missing data were imputed using multiple imputation. Bootstrapping was used to evaluate the cost-effectiveness of the treatments. RESULTS: Cranberry prophylaxis was less effective than TMP-SMX prophylaxis, but the differences in clinical outcomes were not statistically significant. Costs after 12 months in the cranberry group were statistically significantly higher than in the TMP-SMX group (mean difference €249, 95% confidence interval 70 to 516). Cost-effectiveness planes and cost-effectiveness acceptability curves showed that cranberry prophylaxis to prevent UTIs is less effective and more expensive than (dominated by) TMP-SMX prophylaxis. CONCLUSION: In premenopausal women with recurrent UTIs, cranberry prophylaxis is not cost-effective compared to TMP-SMX prophylaxis. However, it was not possible to take into account costs attributed to increased antibiotic resistance within the framework of this randomized trial; modeling studies are recommended to investigate these costs. Moreover, although we based the dosage of cranberry extract on available evidence, this may not be the optimal dosage. Results may change when this optimal dosage is identified. TRIAL REGISTRATION: ISRCTN.org ISRCTN50717094 Public Library of Science 2014-04-04 /pmc/articles/PMC3976255/ /pubmed/24705418 http://dx.doi.org/10.1371/journal.pone.0091939 Text en © 2014 Bosmans et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Bosmans, Judith E. Beerepoot, Mariëlle A. J. Prins, Jan M. ter Riet, Gerben Geerlings, Suzanne E. Cost-Effectiveness of Cranberries vs Antibiotics to Prevent Urinary Tract Infections in Premenopausal Women: A Randomized Clinical Trial |
title | Cost-Effectiveness of Cranberries vs Antibiotics to Prevent Urinary Tract Infections in Premenopausal Women: A Randomized Clinical Trial |
title_full | Cost-Effectiveness of Cranberries vs Antibiotics to Prevent Urinary Tract Infections in Premenopausal Women: A Randomized Clinical Trial |
title_fullStr | Cost-Effectiveness of Cranberries vs Antibiotics to Prevent Urinary Tract Infections in Premenopausal Women: A Randomized Clinical Trial |
title_full_unstemmed | Cost-Effectiveness of Cranberries vs Antibiotics to Prevent Urinary Tract Infections in Premenopausal Women: A Randomized Clinical Trial |
title_short | Cost-Effectiveness of Cranberries vs Antibiotics to Prevent Urinary Tract Infections in Premenopausal Women: A Randomized Clinical Trial |
title_sort | cost-effectiveness of cranberries vs antibiotics to prevent urinary tract infections in premenopausal women: a randomized clinical trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976255/ https://www.ncbi.nlm.nih.gov/pubmed/24705418 http://dx.doi.org/10.1371/journal.pone.0091939 |
work_keys_str_mv | AT bosmansjudithe costeffectivenessofcranberriesvsantibioticstopreventurinarytractinfectionsinpremenopausalwomenarandomizedclinicaltrial AT beerepootmarielleaj costeffectivenessofcranberriesvsantibioticstopreventurinarytractinfectionsinpremenopausalwomenarandomizedclinicaltrial AT prinsjanm costeffectivenessofcranberriesvsantibioticstopreventurinarytractinfectionsinpremenopausalwomenarandomizedclinicaltrial AT terrietgerben costeffectivenessofcranberriesvsantibioticstopreventurinarytractinfectionsinpremenopausalwomenarandomizedclinicaltrial AT geerlingssuzannee costeffectivenessofcranberriesvsantibioticstopreventurinarytractinfectionsinpremenopausalwomenarandomizedclinicaltrial |